67 related articles for article (PubMed ID: 2271934)
1. Chronic testosterone propionate treatment decreases the concentration of [3H]quipazine binding at 5-HT3 receptors in the amygdala of the castrated male rat.
Mendelson SD; McEwen BS
Brain Res; 1990 Oct; 528(2):339-43. PubMed ID: 2271934
[TBL] [Abstract][Full Text] [Related]
2. Autoradiography of [3H]quipazine in rodent brain.
Perry DC
Eur J Pharmacol; 1990 Oct; 187(1):75-85. PubMed ID: 2272355
[TBL] [Abstract][Full Text] [Related]
3. Improvement of 5-HT3 receptor binding assay: enhancement of specific [3H]quipazine binding with Triton X-100-treated membranes from rat cortex.
Une T; Furukawa K; Komiya M
Jpn J Pharmacol; 1991 Oct; 57(2):197-203. PubMed ID: 1812298
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
5. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.
Milburn CM; Peroutka SJ
J Neurochem; 1989 Jun; 52(6):1787-92. PubMed ID: 2566650
[TBL] [Abstract][Full Text] [Related]
7. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
8. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
9. The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.
Kilpatrick GJ; Jones BJ; Tyers MB
Neurosci Lett; 1988 Nov; 94(1-2):156-60. PubMed ID: 3241663
[TBL] [Abstract][Full Text] [Related]
10. Testosterone modulates oxytocin binding in the hypothalamus of castrated male rats.
Johnson AE; Coirini H; McEwen BS; Insel TR
Neuroendocrinology; 1989 Aug; 50(2):199-203. PubMed ID: 2550840
[TBL] [Abstract][Full Text] [Related]
11. Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.
Peroutka SJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):472-5. PubMed ID: 3244388
[TBL] [Abstract][Full Text] [Related]
12. [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.
Peroutka SJ; Hamik A
Eur J Pharmacol; 1988 Mar; 148(2):297-9. PubMed ID: 3378579
[No Abstract] [Full Text] [Related]
13. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
[TBL] [Abstract][Full Text] [Related]
14. Reversal of testosterone-induced dominance by the serotonergic agonist quipazine.
Bonson KR; Winter JC
Pharmacol Biochem Behav; 1992 Aug; 42(4):809-13. PubMed ID: 1513863
[TBL] [Abstract][Full Text] [Related]
15. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
[TBL] [Abstract][Full Text] [Related]
16. Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
Glennon RA; Ismaiel AE; McCarthy BG; Peroutka SJ
Eur J Pharmacol; 1989 Sep; 168(3):387-92. PubMed ID: 2583244
[TBL] [Abstract][Full Text] [Related]
17. Aggressive behavior inhibition by serotonin and quipazine injected into the amygdala in the rat.
Puciłowski O; Płaźnik A; Kostowski W
Behav Neural Biol; 1985 Jan; 43(1):58-68. PubMed ID: 4039562
[TBL] [Abstract][Full Text] [Related]
18. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
[TBL] [Abstract][Full Text] [Related]
19. Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
Gehlert DR; Gackenheimer SL; Wong DT; Robertson DW
Brain Res; 1991 Jul; 553(1):149-54. PubMed ID: 1933271
[TBL] [Abstract][Full Text] [Related]
20. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]